Limb Occlusion Pressure Tourniquets to Decrease Pain After Surgery (LOP)

March 31, 2026 updated by: Shari Liberman, The Methodist Hospital Research Institute
Currently a standard tourniquet pressure is used for orthopedic surgeries. High tourniquet pressure had been associated with adverse side effects such as ischemia, muscle weakness, and post operative pain. Limb Occlusion Pressure, LOP, is based off the patient's systolic blood pressure plus a safety margin and is typically much lower than standard tourniquet pressure. The aim of this study is to determine if using LOP during orthopedic surgeries decreases post-operative pain and opioid consumption and improves patient's outcomes.

Study Overview

Status

Active, not recruiting

Detailed Description

The study will start for each subject in the clinic setting during a standard pre-operative office visit. Consent for the study will be obtained after explaining all aspects of the study. The subjects will be randomly separated into two groups. Half of the subjects will have their procedure performed under standard tourniquet pressure, and the other half of the subjects will have their procedure performed with a distal photoplenthysmography probe that will calculate Limb Occlusion Pressure and inflate the tourniquet to the calculated Limb Occlusion Pressure. The subject will undergo their scheduled procedure in the operating room. The subject will also keep a daily pain and opioid consumption diary at home for two weeks after the surgery. The subject will complete patient outcome questionnaires before the surgery, two weeks after the operation, and 8 weeks after the operation to assess patient outcomes. The subject can complete the questionnaires at home, but if they do not, they will have the option to fill the out during their clinic visits. The patient's pre and post OP questionaries' will be the indicators for patient outcomes. All of the standardized questionnaires give calculated scores based off the patients' responses. As the subject improves their score will increase.The research team can compare change in score between the two groups and change with in groups to access patient outcomes.

To maintain the double blind nature of the study, the tourniquet will be placed, inflated, and draped over before the surgeon enters the operating room. Someone else on the research team, one of the coordinators or one of the residents will record the patients' systolic blood pressure and cuff pressure of the tourniquet before the attending enters the OR. This way the surgeon is still blind to the cuff pressure technique used, LOP or STP, when they rate the quality of the bloodless field after the surgery using a VAS scale.

All of these documents are attached on the summary page under additional documents on the Psycho-Physiological Testing page under number 1. List all the measures/instruments that will be used for this study. The VAS pain and opioid consumption diary is titled LOP pain diary cover page and LOP pain diary. The questionnaires that will be used are DASH, IKDC Subject Knee Evaluation Form, KOOS Junior, KOOS Lysholm, Marx, Michigan Hand Outcomes, Patient Rated Wrist Evaluation, Promis Bank v 1.2 Physical Function, PROMIS SF v 1.1 Global Health, and Tegner Activity Level Scale.

Study Type

Interventional

Enrollment (Estimated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Houston Methodist Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The research team will test the central hypothesis that LOP tourniquets will decrease pain and opioid use and improve patients outcomes on healthy adults (above the age of 18) undergoing either open carpal tunnel release, open reduction internal fixation distal radius fracture, cubital tunnel release, trigger finger release, thumb CMC arthroplasty, anterior cruciate ligament reconstruction, or total knee replacements

Exclusion Criteria:

  1. Prescription pain medications for chronic conditions (> 6 weeks)
  2. Patients who cannot use a tourniquet:( ex. Certain patients with fistulas or PVD, certain patient with Peripheral Vascular Disease)
  3. Prior trauma or surgery to the observed limb.
  4. Hypotension or hypertension that prevents accurate distal photoplenthysmography probe reading.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control - Standard pneumatic tourniquet pressure
This group receives the standard pneumatic tourniquet pressure during surgery like they would during standard of care.
Experimental: Experimental - Limb occlusion pressure
This group receives a slightly lower tourniquet pressure than they would during standard of care. This lowered limb occlusion pressure is determined by the tourniquet device.
This intervention involves lower tourniquet pressure than the standard of care. There is no change to tourniquet time or how the surgery is performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative surgical site pain
Time Frame: Pain will be recorded as an average of three reported VAS recordings throughout each day for 14-days following surgery. Will compare change in average pain relative baseline pre-op (0) (within group) at each day post-surgery for 14 days
Visual analog scale from 0 (no pain) to 10 (worst pain imaginable)
Pain will be recorded as an average of three reported VAS recordings throughout each day for 14-days following surgery. Will compare change in average pain relative baseline pre-op (0) (within group) at each day post-surgery for 14 days
Postoperative tourniquet site pain
Time Frame: Pain will be recorded as an average of three reported VAS recordings throughout each day for 14-days following surgery. Will compare change in average pain relative baseline pre-op (0) (within group) at each day post-surgery for 14 days
Visual analog scale from 0 (no pain) to 10 (worst pain imaginable)
Pain will be recorded as an average of three reported VAS recordings throughout each day for 14-days following surgery. Will compare change in average pain relative baseline pre-op (0) (within group) at each day post-surgery for 14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative opioid usage
Time Frame: Once a day, every day for 2 weeks postoperatively
Patients record the name of the opioid, dosage, and number of pills taken. These are standardized using the morphine milligram equivalents formula.
Once a day, every day for 2 weeks postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrick McCulloch, MD, The Methodist Hospital Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2018

Primary Completion (Actual)

July 28, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

May 11, 2020

First Submitted That Met QC Criteria

May 14, 2020

First Posted (Actual)

May 15, 2020

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 31, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00018544

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Limb Occlusion Pressure

Clinical Trials on Experimental - Limb Occlusion pressure

Subscribe